M-VEC (METHOTREXATE, VINBLASTLNE, 4'-EPIRUBICIN AND CISPLATIN) COMBINED WITH GLYCOSYLATED RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR (rhG-CSF) FOR THE TREATMENT OF TRANSITIONAL CELL CARCINOMA OF UROTHELIUM : REDUCTION IN TOXICITY PRODUCED BY rhG-CSF

Search this Article

Author(s)

    • IGAWA Mikio
    • Department of Urology, Hiroshima University School of Medicine
    • USUI Tsuguru
    • Department of Urology, Hiroshima University School of Medicine

Journal

  • International journal of urology

    International journal of urology 1(3), 223-227, 1994-09-01

References:  12

Codes

  • NII Article ID (NAID)
    10008459790
  • NII NACSIS-CAT ID (NCID)
    AA11042471
  • Text Lang
    ENG
  • Article Type
    ART
  • ISSN
    09198172
  • Data Source
    CJP 
Page Top